JNJ vs HUM
By Alex · Tickerpine
Johnson & Johnson vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | HUM |
|---|---|---|
| Price | $273.14 | $389.71 |
| Market cap | $658.24B | $46.80B |
| P/E ratio | 31.7 | 36.9 |
| ROE | 25.74% | 6.89% |
| Profit margin | 21.48% | 0.88% |
| Revenue growth | 6.60% | 26.20% |
| Dividend yield | 1.96% | 0.92% |
| Beta | 0.23 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs HUM in plain English
- JNJ is the bigger company — about 14.1× the market cap of HUM.
- JNJ is cheaper on earnings (P/E 31.7 vs 36.9).
- JNJ earns a higher return on equity (26% vs 7%).
- HUM is growing revenue faster (26% vs 7%).
- JNJ has the higher dividend yield (1.96% vs 0.92%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.